Kang R, Zeh HJ, Lotze MT, Tang D
A Phase I/II Trial of the KSP Inhibitor ARRY-520 In Relapsed/Refractory Multiple Myeloma
Understanding these differences can help you choose the right supplement based on your fitness goals, whether thats fat loss, strength, or better performance
About Us Privacy Policy Terms of Use Breaking News Explainers Listen Live Friday, July 24, 2026 Home News Regional News Ahafo Region Ashanti Region Bono East Region Bono Region Central Region Eastern Region Greater Accra Region Northern Region North East Region Oti Region Savanna Region Upper East Region Upper West Region Volta Region Western Region Western North Region Sports World Cup Politics Business Entertainment Articles Explainers Editorials No Result View All Result Home News Regional News Ahafo Region Ashanti Region Bono East Region Bono Region Central Region Eastern Region Greater Accra Region Northern Region North East Region Oti Region Savanna Region Upper East Region Upper West Region Volta Region Western Region Western North Region Sports World Cup Politics Business Entertainment Articles Explainers Editorials No Result View All Result No Result View All Result 44 No Result View All Result Home News Regional News Ahafo Region Ashanti Region Bono East Region Bono Region Central Region Eastern Region Greater Accra Region Northern Region North East Region Oti Region Savanna Region Upper East Region Upper West Region Volta Region Western Region Western North Region Sports World Cup Politics Business Entertainment Articles Explainers Editorials 2024 All Rights Reserved Citi Newsroom .
If switching to a plant-based diet, it usually takes years before a clinically manifest deficiency develops, especially taking the reserve capacity of the body into consideration
Currently, Phase II trials are underway to evaluate the combination of IMSA101 with immune checkpoint inhibitors and RT (NCT05846659, NCT05846646, and NCT06601296)
